$3,630.46 speaking Payment -- Boehringer Ingelheim to Dr. Paul Turner
This page provides a detailed analysis of a $3,630.46 speaking payment from Boehringer Ingelheim to Dr. Paul Turner. Data is from the CMS Open Payments (Sunshine Act) database.
Payment Details
| Field | Value |
|---|---|
| Amount | $3,630.46 |
| Payment Type | speaking |
| Payment Nature | Compensation for serving as faculty or as a speaker |
| Pharmaceutical Company | Boehringer Ingelheim |
| Physician | Dr. Paul Turner |
| NPI Number | 1807365654 |
| Physician Specialty | Internal Medicine |
| Location | City, MD |
| Date of Payment | 2025-02-28 |
| Related Drug/Device | Skyrizi |
Understanding speaking Payments
Speaking and education payments compensate physicians for presenting at conferences, continuing medical education (CME) events, and promotional speaking engagements. These payments often cover honoraria, preparation time, and travel expenses. Speaking fees are among the highest-value payment categories and have attracted significant attention from researchers studying potential conflicts of interest.
Related Reports
Data from CMS Open Payments (Sunshine Act). Payment does not imply wrongdoing. AI analysis is not medical or legal advice. Consult your healthcare provider about any concerns.